Making a SPLASH! Long-acting Injectables for vulnerable populations with HIV

The clinical innovation of antiretroviral treatment for HIV is a major public health victory that has transformed the shape of the epidemic. Healthcare professionals must remain committed to reaching every person with HIV, which means not only developing new clinical technologies, but also the strategies to implement them equitably. Long-acting injectable antiretroviral treatment (LAI-ART) is the newest clinical tool for ending the epidemic. How can we make sure that it reaches the people living with HIV who are not virally suppressed? In today’s episode, I speak with Dr. Monica Gandhi about her research increasing access to LAI-ART among vulnerable populations. Related Content: Dr. Gandhi’s newest publication, “Demonstration Project of Long-Acting Antiretroviral Therapy in a Diverse Population of People With HIV” https://www.acpjournals.org/doi/10.7326/M23-0788 Dr. Gandhi’s faculty profile at UCSF: https://profiles.ucsf.edu/monica.gandhi NYS Injectable ART Guidelines: https://www.hivguidelines.org/antiretroviral-therapy/art-injectable/  CEI toll free line for NYS providers: 866-637-2342 https://ceitraining.org/